NOTES PAYABLE |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Defined Benefit Plan Disclosure [Line Items] | |
| NOTES PAYABLE |
NOTE 3 – NOTES PAYABLE, RELATED PARTY
During 2023, the Company’s Chief Executive Officer made three loans to the Company for aggregate principal amount of $260 pursuant to terms of the note agreements. During 2025, the Company’s Chief Executive Officer made three additional loans to the Company for aggregate principal amount of $330 pursuant to terms of the note agreements. The notes have relatively similar terms, are unsecured, and accrue interest at 3.5% per annum. As of March 31, 2026, the aggregate outstanding balance of the loans including accrued interest is $611, with $166 due in April 2026, $172 due in May 2026, $71 due in August 2026, $71 due in September 2026, and $131 due in October 2026.
|
| Nonrelated Party [Member] | |
| Defined Benefit Plan Disclosure [Line Items] | |
| NOTES PAYABLE |
NOTE 5 – NOTES PAYABLE
On December 23 2025, the Company entered into the WWCM Loan Agreement with WWCM, pursuant to which the Company borrowed net proceeds of $399, after deducting fees as outlined in the WWCM Loan Agreement.
The loan amount is $500, with a loan origination fee of $20, providing for an advance amount of $480. The loan is to be paid in 48 weekly payments of $13 with the first six payments paid in advance and deducted from the initial funding. Net proceeds of $399 were received by the Company on December 26, 2025. The total repayment obligation to the Company is $640 resulting in an effective rate of approximately 34%. As of March 31, 2026, the outstanding loan balance including interest and fees is $365.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The entire disclosure for long-term debt. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|